{"transactions":[{"id":978189,"issuer":{"id":4839,"kind":"organization","name":"Corvus Pharmaceuticals, Inc."},"owners":[{"id":72117,"kind":"person","name":"LEA LEIV","position":1,"cik":"0000939012","reported_name":"LEA LEIV","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-12-08T16:21:35.000Z","date":"2025-12-04","kind":"grant","planned":false,"acquired":true,"shares":400000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The underlying shares subject to the option vest and become exercisable as to 1/36th of the shares subject to the option in successive, equal monthly installments measured from December 4, 2025, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date."}],"balance_after":400000,"derivative":{"exercise_price":8.81,"expiration_date":"2035-12-04","underlying":"Common Stock","underlying_shares":400000},"source":{"system":"sec-edgar","filing":"0001610717-25-000409","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/939012/000161071725000409/form4.xml","form_type":"4"}},{"id":1323390,"issuer":{"id":4839,"kind":"organization","name":"Corvus Pharmaceuticals, Inc."},"owners":[{"id":72117,"kind":"person","name":"LEA LEIV","position":1,"cik":"0000939012","reported_name":"LEA LEIV","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-12-23T16:39:11.000Z","date":"2024-12-20","kind":"grant","planned":false,"acquired":true,"shares":300000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The underlying shares subject to the option vest and become exercisable as to 1/36th of the shares subject to the option in successive, equal monthly installments measured from December 20, 2024, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date."}],"balance_after":300000,"derivative":{"exercise_price":4.99,"expiration_date":"2034-12-20","underlying":"Common Stock","underlying_shares":300000},"source":{"system":"sec-edgar","filing":"0001610717-24-000551","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/939012/000161071724000551/form4.xml","form_type":"4"}},{"id":1718325,"issuer":{"id":4839,"kind":"organization","name":"Corvus Pharmaceuticals, Inc."},"owners":[{"id":72117,"kind":"person","name":"LEA LEIV","position":1,"cik":"0000939012","reported_name":"LEA LEIV","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-12-08T16:08:13.000Z","date":"2023-12-06","kind":"grant","planned":false,"acquired":true,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The underlying shares subject to the option vest and become exercisable as to 1/36th of the shares subject to the option in successive, equal monthly installments measured from December 6, 2023, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date."}],"balance_after":200000,"derivative":{"exercise_price":1.64,"expiration_date":"2033-12-06","underlying":"Common Stock","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0001610717-23-000394","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/939012/000161071723000394/form4.xml","form_type":"4"}},{"id":2085623,"issuer":{"id":4839,"kind":"organization","name":"Corvus Pharmaceuticals, Inc."},"owners":[{"id":72117,"kind":"person","name":"LEA LEIV","position":1,"cik":"0000939012","reported_name":"LEA LEIV","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-12-15T16:33:15.000Z","date":"2022-12-14","kind":"purchase","acquired":true,"shares":4000,"price":0.841,"value":3364.0,"ownership":{"direct":false,"nature":"By IRA"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These shares are held by Leiv Lea IRA Contributory."}],"balance_after":133238,"source":{"system":"sec-edgar","filing":"0001567619-22-021651","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/939012/000156761922021651/doc1.xml","form_type":"4"}},{"id":2085622,"issuer":{"id":4839,"kind":"organization","name":"Corvus Pharmaceuticals, Inc."},"owners":[{"id":72117,"kind":"person","name":"LEA LEIV","position":1,"cik":"0000939012","reported_name":"LEA LEIV","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-12-15T16:33:15.000Z","date":"2022-12-13","kind":"purchase","acquired":true,"shares":30000,"price":0.7425,"value":22275.0,"ownership":{"direct":false,"nature":"By IRA"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $0.7255 to $0.7806, inclusive. Upon request, the Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the SEC full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These shares are held by Leiv Lea IRA Contributory."}],"balance_after":129238,"source":{"system":"sec-edgar","filing":"0001567619-22-021651","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/939012/000156761922021651/doc1.xml","form_type":"4"}},{"id":2186098,"issuer":{"id":4839,"kind":"organization","name":"Corvus Pharmaceuticals, Inc."},"owners":[{"id":72117,"kind":"person","name":"LEA LEIV","position":1,"cik":"0000939012","reported_name":"LEA LEIV","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-08-15T18:49:39.000Z","date":"2022-08-11","kind":"grant","acquired":true,"shares":160000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The underlying shares subject to the option vest and become exercisable as to one-forty eighth (1/48th) of the shares subject to the option in successive, equal monthly installments measured from August 11, 2022, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date."}],"balance_after":160000,"derivative":{"exercise_price":0.965,"expiration_date":"2032-08-11","underlying":"Common Stock","underlying_shares":160000},"source":{"system":"sec-edgar","filing":"0001567619-22-016299","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/939012/000156761922016299/doc1.xml","form_type":"4"}},{"id":2328943,"issuer":{"id":4839,"kind":"organization","name":"Corvus Pharmaceuticals, Inc."},"owners":[{"id":72117,"kind":"person","name":"LEA LEIV","position":1,"cik":"0000939012","reported_name":"LEA LEIV","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-03-17T19:10:49.000Z","date":"2022-03-17","kind":"purchase","acquired":true,"shares":13878,"price":1.65,"value":22898.7,"ownership":{"direct":false,"nature":"By IRA"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $1.62 to $1.66 inclusive. Upon request, the Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the SEC full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These shares are held by Leiv Lea IRA Contributory."}],"balance_after":99238,"source":{"system":"sec-edgar","filing":"0001567619-22-007173","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/939012/000156761922007173/doc1.xml","form_type":"4"}},{"id":2328942,"issuer":{"id":4839,"kind":"organization","name":"Corvus Pharmaceuticals, Inc."},"owners":[{"id":72117,"kind":"person","name":"LEA LEIV","position":1,"cik":"0000939012","reported_name":"LEA LEIV","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-03-17T19:10:49.000Z","date":"2022-03-16","kind":"purchase","acquired":true,"shares":35160,"price":1.54,"value":54146.4,"ownership":{"direct":false,"nature":"By IRA"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $1.45 to $1.60 inclusive. Upon request, the Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the SEC full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These shares are held by Leiv Lea IRA Contributory."}],"balance_after":85360,"source":{"system":"sec-edgar","filing":"0001567619-22-007173","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/939012/000156761922007173/doc1.xml","form_type":"4"}},{"id":2572464,"issuer":{"id":4839,"kind":"organization","name":"Corvus Pharmaceuticals, Inc."},"owners":[{"id":72117,"kind":"person","name":"LEA LEIV","position":1,"cik":"0000939012","reported_name":"LEA LEIV","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-09-13T16:59:52.000Z","date":"2021-09-09","kind":"grant","acquired":true,"shares":160000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The underlying shares subject to the option vest and become exercisable as to one-forty eighth (1/48th) of the shares subject to the option in successive, equal monthly installments measured from September 9, 2021, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date."}],"balance_after":160000,"derivative":{"exercise_price":2.6,"expiration_date":"2031-09-09","underlying":"Common Stock","underlying_shares":160000},"source":{"system":"sec-edgar","filing":"0001567619-21-017014","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/939012/000156761921017014/doc1.xml","form_type":"4"}},{"id":2940918,"issuer":{"id":4839,"kind":"organization","name":"Corvus Pharmaceuticals, Inc."},"owners":[{"id":72117,"kind":"person","name":"LEA LEIV","position":1,"cik":"0000939012","reported_name":"LEA LEIV","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-12-17T16:17:00.000Z","date":"2020-12-16","kind":"grant","acquired":true,"shares":160000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The underlying shares subject to the option vest and become exercisable as to one-forty eighth (1/48th) of the shares subject to the option in successive, equal monthly installments measured from December 16, 2020, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date."}],"balance_after":160000,"derivative":{"exercise_price":4.01,"expiration_date":"2030-12-16","underlying":"Common Stock","underlying_shares":160000},"source":{"system":"sec-edgar","filing":"0001567619-20-021268","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/939012/000156761920021268/doc1.xml","form_type":"4"}},{"id":3341438,"issuer":{"id":4839,"kind":"organization","name":"Corvus Pharmaceuticals, Inc."},"owners":[{"id":72117,"kind":"person","name":"LEA LEIV","position":1,"cik":"0000939012","reported_name":"LEA LEIV","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-12-16T16:13:50.000Z","date":"2019-12-12","kind":"grant","acquired":true,"shares":160000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The underlying shares subject to the option vest and become exercisable as to one-forty eighth (1/48th) of the shares subject to the option in successive, equal monthly installments measured from December 12, 2019, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date."}],"balance_after":160000,"derivative":{"exercise_price":3.54,"expiration_date":"2029-12-12","underlying":"Common Stock","underlying_shares":160000},"source":{"system":"sec-edgar","filing":"0001567619-19-023143","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/939012/000156761919023143/doc1.xml","form_type":"4"}},{"id":3496232,"issuer":{"id":4839,"kind":"organization","name":"Corvus Pharmaceuticals, Inc."},"owners":[{"id":72117,"kind":"person","name":"LEA LEIV","position":1,"cik":"0000939012","reported_name":"LEA LEIV","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock, $0.0001 par value","published_at":"2019-06-10T16:12:59.000Z","date":"2019-06-07","kind":"purchase","acquired":true,"shares":10000,"price":3.38,"value":33800.0,"ownership":{"direct":false,"nature":"By IRA"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted price. These Shares were purchased in multiple transactions at prices ranging from $3.29 to $3.40 inclusive. Upon request, the Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the SEC full information regarding the Shares purchased at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These shares are held by Leiv Lea IRA Contributory."}],"balance_after":50200,"source":{"system":"sec-edgar","filing":"0001567619-19-013152","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/939012/000156761919013152/doc1.xml","form_type":"4"}},{"id":3496231,"issuer":{"id":4839,"kind":"organization","name":"Corvus Pharmaceuticals, Inc."},"owners":[{"id":72117,"kind":"person","name":"LEA LEIV","position":1,"cik":"0000939012","reported_name":"LEA LEIV","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock, $0.0001 par value","published_at":"2019-06-10T16:12:59.000Z","date":"2019-06-06","kind":"purchase","acquired":true,"shares":15500,"price":3.56,"value":55180.0,"ownership":{"direct":false,"nature":"By IRA"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted price. These Shares were purchased in multiple transactions at prices ranging from $3.50 to $3.64 inclusive. Upon request, the Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the SEC full information regarding the Shares purchased at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These shares are held by Leiv Lea IRA Contributory."}],"balance_after":40200,"source":{"system":"sec-edgar","filing":"0001567619-19-013152","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/939012/000156761919013152/doc1.xml","form_type":"4"}},{"id":3718378,"issuer":{"id":4839,"kind":"organization","name":"Corvus Pharmaceuticals, Inc."},"owners":[{"id":72117,"kind":"person","name":"LEA LEIV","position":1,"cik":"0000939012","reported_name":"LEA LEIV","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock, $0.0001 par value","published_at":"2018-12-27T16:08:07.000Z","date":"2018-12-21","kind":"purchase","acquired":true,"shares":24700,"price":4.1461,"value":102408.67,"ownership":{"direct":false,"nature":"By IRA"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted price. These Shares were purchased in multiple transactions at prices ranging from $4.13 to $4.17 inclusive.  Upon request, the Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the SEC full information regarding the Shares purchased at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These shares are held by Leiv Lea IRA Contributory."}],"balance_after":24700,"source":{"system":"sec-edgar","filing":"0000899243-18-031810","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/939012/000089924318031810/doc4.xml","form_type":"4"}},{"id":3731256,"issuer":{"id":4839,"kind":"organization","name":"Corvus Pharmaceuticals, Inc."},"owners":[{"id":72117,"kind":"person","name":"LEA LEIV","position":1,"cik":"0000939012","reported_name":"LEA LEIV","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-12-14T16:06:19.000Z","date":"2018-12-12","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The underlying shares subject to the option vest and become exercisable as to one-forty eighth (1/48th) of the shares subject to the option in successive, equal monthly installments measured from December 12, 2018, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date."}],"balance_after":100000,"derivative":{"exercise_price":5.94,"expiration_date":"2028-12-12","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0000899243-18-031057","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/939012/000089924318031057/doc4.xml","form_type":"4"}},{"id":4130771,"issuer":{"id":4839,"kind":"organization","name":"Corvus Pharmaceuticals, Inc."},"owners":[{"id":72117,"kind":"person","name":"LEA LEIV","position":1,"cik":"0000939012","reported_name":"LEA LEIV","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2017-12-15T16:08:14.000Z","date":"2017-12-13","kind":"grant","acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The underlying shares subject to the option vest and become exercisable as to one-forty eighth (1/48th) of the shares subject to the option in successive, equal monthly installments measured from December 13, 2017, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date."}],"balance_after":40000,"derivative":{"exercise_price":10.6,"expiration_date":"2027-12-13","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0000899243-17-028853","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/939012/000089924317028853/doc4.xml","form_type":"4"}},{"id":4457896,"issuer":{"id":4839,"kind":"organization","name":"Corvus Pharmaceuticals, Inc."},"owners":[{"id":72117,"kind":"person","name":"LEA LEIV","position":1,"cik":"0000939012","reported_name":"LEA LEIV","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock, $0.0001 par value","published_at":"2017-02-10T16:18:38.000Z","date":"2016-08-25","kind":"gift","acquired":false,"shares":2047,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Trust"},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"A portion of these shares is subject to a right of repurchase held by the Issuer."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These shares are held by Leiv Lea and Deborah Karlson, Trustees of the Karlson Lea Family Trust UTA dated February 11, 1998 (the \"Karlson Lea Trust\").  Mr. Lea has shared voting, investment and dispositive power over the shares held by the Karlson Lea Trust."}],"balance_after":149206,"source":{"system":"sec-edgar","filing":"0000899243-17-003462","document":"doc5.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/939012/000089924317003462/doc5.xml","form_type":"5"}},{"id":4457895,"issuer":{"id":4839,"kind":"organization","name":"Corvus Pharmaceuticals, Inc."},"owners":[{"id":72117,"kind":"person","name":"LEA LEIV","position":1,"cik":"0000939012","reported_name":"LEA LEIV","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock, $0.0001 par value","published_at":"2017-02-10T16:18:38.000Z","date":"2016-08-25","kind":"gift","acquired":false,"shares":48000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Trust"},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"A portion of these shares is subject to a right of repurchase held by the Issuer."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These shares are held by Leiv Lea and Deborah Karlson, Trustees of the Karlson Lea Family Trust UTA dated February 11, 1998 (the \"Karlson Lea Trust\").  Mr. Lea has shared voting, investment and dispositive power over the shares held by the Karlson Lea Trust."}],"balance_after":151253,"source":{"system":"sec-edgar","filing":"0000899243-17-003462","document":"doc5.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/939012/000089924317003462/doc5.xml","form_type":"5"}},{"id":4529063,"issuer":{"id":4839,"kind":"organization","name":"Corvus Pharmaceuticals, Inc."},"owners":[{"id":72117,"kind":"person","name":"LEA LEIV","position":1,"cik":"0000939012","reported_name":"LEA LEIV","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2016-12-08T19:03:47.000Z","date":"2016-12-07","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The underlying shares subject to the option vest and become exercisable as to one-forty-eighth (1/48th) of the shares subject to the option in successive, equal monthly installments measured from December 7, 2016, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date."}],"balance_after":25000,"derivative":{"exercise_price":16.37,"expiration_date":"2026-12-07","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001140361-16-089146","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/939012/000114036116089146/doc1.xml","form_type":"4"}}]}